building
Exclusive: Medivation succumbs to pressure to explore sale -sources
May 9, 2016 by elegant · Leave a Comment
U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to obtain confidential information about the company, the people said. Sanofi made its
Go here to read the rest:
Exclusive: Medivation succumbs to pressure to explore sale -sources
building
Tribune Publishing adopts poison pill to stop Gannett bid
May 9, 2016 by admin · Leave a Comment
(Reuters) – Newspaper publisher Tribune Publishing Co said its board had adopted a shareholder rights plan – popularly known as a “poison pill” – in a bid to thwart Gannett Co Inc's unsolicited takeover offer. Tribune shares fell nearly 6 percent in morning trading on Monday, while Gannett shares were little
See the rest here:
Tribune Publishing adopts poison pill to stop Gannett bid
building
New drugs fuel strong Pfizer results; company raises 2016 forecasts
May 3, 2016 by elegant · Leave a Comment
Pfizer said sales would be hurt in the fourth quarter of 2016, however, when those added days will be offset by fewer days. Pfizer walked away from the deal after the U.S. Treasury issued new rules curbing tax inversion deals, under which American companies move overseas to cut taxes. Many analysts believe Pfizer needs to buy new medicines or entire biotech companies to ensure competitive earnings growth.
Read more here:
New drugs fuel strong Pfizer results; company raises 2016 forecasts
building
Exclusive: Commodity trader Cargill restructures, cuts jobs – sources
November 15, 2015 by admin · Leave a Comment
By Sarah McFarlane LONDON (Reuters) – Cargill Inc [CARG.UL], one of the world's largest privately held corporations, has launched a restructuring that includes job cuts, one company source and four industry sources said on Friday, the latest casualty of a downturn in the farm economy. The 150-year-old company, a top commodities trader, is also closing offices, two of the industry sources said. The cutbacks at the Minnesota-based company come as global agricultural companies are under pressure from slumping commodity prices…
Read more:
Exclusive: Commodity trader Cargill restructures, cuts jobs – sources
building
Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules
November 15, 2015 by creative · Leave a Comment
Pfizer Inc's buyout bid for Allergan Plc has financial markets on edge over a possible new move by the U.S. Treasury Department against tax-inversion deals, but the outlook for any such
Here is the original post:
Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules